Editorial: Non-Dopaminergic Systems in Parkinson’s Disease

Editorial: Non-Dopaminergic Systems in Parkinson’s Disease

Bibliographic Details
Main Authors:	Cristina Miguelez, Philippe De Deurwaerdère, Véronique Sgambato
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-09-01
Series:	Frontiers in Pharmacology
Subjects:	L-DOPA serotonin sleep noradrenaline GABA non-motor symptoms
Online Access:	https://www.frontiersin.org/article/10.3389/fphar.2020.593822/full

Similar Items

The Noradrenergic System in Parkinson’s Disease
by: Elena Paredes-Rodriguez, et al.
Published: (2020-04-01)

Emerging dysfunctions consequent to combined monoaminergic depletions in parkinsonism
by: Claire Delaville, et al.
Published: (2012-02-01)

Noradrenaline and Parkinson's disease
by: Claire eDelaville, et al.
Published: (2011-05-01)

Influence of depressive symptoms on dopaminergic treatment of Parkinson’s disease
by: Alexandru eHanganu, et al.
Published: (2014-09-01)

L-Dopa and Brain Serotonin System Dysfunction
by: Branden J. Stansley, et al.
Published: (2015-03-01)

Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease
by: Sylvia Navailles, et al.
Published: (2011-02-01)

5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model
by: Elisabetta Tronci, et al.
Published: (2013-12-01)

Monoaminergic control of spinal locomotor networks in SOD1G93A newborn mice
by: Léa eMilan, et al.
Published: (2014-07-01)

Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson’s disease
by: Sandy eStayte, et al.
Published: (2014-08-01)

Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
by: Sandy eStayte, et al.
Published: (2014-05-01)

The Multimodal Serotonergic Agent Vilazodone Inhibits L-DOPA-Induced Gene Regulation in Striatal Projection Neurons and Associated Dyskinesia in an Animal Model of Parkinson’s Disease
by: Feras Altwal, et al.
Published: (2020-10-01)

Simulated Microgravity Subtlety Changes Monoamine Function across the Rat Brain
by: Alexandra Gros, et al.
Published: (2021-10-01)

Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease
by: Eunju Shin, et al.
Published: (2012-09-01)

Role of 5-HT1A Receptor in Vilazodone-Mediated Suppression of L-DOPA-Induced Dyskinesia and Increased Responsiveness to Cortical Input in Striatal Medium Spiny Neurons in an Animal Model of Parkinson’s Disease
by: Feras Altwal, et al.
Published: (2021-09-01)

Neuropathology of the Brainstem to Mechanistically Understand and to Treat Alzheimer’s Disease
by: Ágoston Patthy, et al.
Published: (2021-04-01)

Worse Sleep Quality Aggravates the Motor and Non-Motor Symptoms in Parkinson's Disease
by: Qu Yi, et al.
Published: (2022-06-01)

Morphological changes in serotoninergic neurites in the striatum and globus pallidus in levodopa primed MPTP treated common marmosets with dyskinesia
by: Bai-Yun Zeng, et al.
Published: (2010-12-01)

Dopaminergic and non-dopaminergic mechanisms of non-motor symptoms of Parkinson disease
by: Titus Mihai Vasile, et al.
Published: (2012-12-01)

Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and L-DOPA-induced dyskinesia
by: Joanna García, et al.
Published: (2011-09-01)

Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity
by: Nora-Isabell Griebsch, et al.
Published: (2022-10-01)

Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit
by: Bandar Alharbi, et al.
Published: (2024-03-01)

Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications
by: Cristina Miguelez, et al.
Published: (2017-09-01)

Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson’s Disease
by: Srijan Acharya, et al.
Published: (2021-04-01)

Non-dopaminergic Alterations in Depression-Like FSL Rats in Experimental Parkinsonism and L-DOPA Responses
by: Nicoletta Schintu, et al.
Published: (2020-03-01)

Interaction between the 5-HT system and the basal ganglia: Functional implication and therapeutic perspective in Parkinson’s disease
by: Cristina eMiguelez, et al.
Published: (2014-03-01)

Pathophysiological Mechanisms and Experimental Pharmacotherapy for L-Dopa-Induced Dyskinesia
by: Fabbrini A, et al.
Published: (2021-04-01)

Molecular mechanism of noradrenaline during the stress-induced major depressive disorder
by: Kenjiro Seki, et al.
Published: (2018-01-01)

Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson’s Disease?
by: Javier Navarro-Zaragoza, et al.
Published: (2021-03-01)

A Public Data Set With Ground Reaction Forces of Human Balance in Individuals With Parkinson's Disease
by: Claudia Eunice Neves de Oliveira, et al.
Published: (2022-04-01)

The Relation Between the Noise Stress Effects and Neurotransmitters, Sex Hormones Levels in the Male and Female Balb/c Mice
by: Zainab A. A. Al-Shammary, et al.
Published: (2023-02-01)

Reticular Formation and Pain: The Past and the Future
by: Isabel Martins, et al.
Published: (2017-07-01)

Reassessment of amphetamine- and phencyclidine-induced locomotor hyperactivity as a model of psychosis-like behavior in rats
by: Snezana Kusljic, et al.
Published: (2022-01-01)

THALAMIC NEUROMODULATION AND ITS IMPLICATIONS FOR EXECUTIVE NETWORKS
by: Carmen eVarela
Published: (2014-06-01)

Brain substrates of behavioral programs associated with self-regulation
by: Mattie Tops, et al.
Published: (2010-09-01)

Role of glycogenolysis in memory and learning: regulation by noradrenaline, serotonin and ATP
by: Marie Elizabeth Gibbs
Published: (2016-01-01)

ACUTE EFFECTS OF RESTRAINT, SHOCK AND TRAINING IN THE ELEVATED T-MAZE ON NORADRENALINE AND SEROTONIN SYSTEMS OF THE PREFRONTAL CORTEX
by: NORMA LAURA GARCÍA-SALDÍVAR, et al.

Revisiting antagonist effects in hypoglossal nucleus: Brainstem circuit for the state-dependent control of hypoglossal motoneurons: A hypothesis.
by: Victor B. Fenik, et al.
Published: (2015-12-01)

Effects of L-DOPA and STN-HFS dyskinesiogenic treatments on NR2B regulation in basal ganglia in the rat model of Parkinson's disease
by: Adrien Quintana, et al.
Published: (2012-12-01)

Non-motor Symptoms of Parkinson's Disease
by: Jyh-Gong Gabriel Hou, et al.
Published: (2007-06-01)

Behavioral effects of zonisamide on L-DOPA-induced dyskinesia in Parkinson's disease model mice
by: Hiromi Sano, et al.
Published: (2023-06-01)